Insulet
PODD
#2071
Rank
C$13.99 B
Marketcap
C$201.76
Share price
1.20%
Change (1 day)
-56.81%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): C$0.64 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.90 Billion. In 2025 the company made an earning of C$0.55 Billion, an increase over its 2024 earnings that were of C$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.64 B16.84%
2025 C$0.55 B16.3%
2024 C$0.47 B36.76%
2023 C$0.34 B481.9%
2022 C$59.91 M-45.24%
2021 C$0.10 B43.35%
2020 C$76.32 M18.51%
2019 C$64.4 M41.16%
2018 C$45.62 M-711.95%
2017 -C$7.46 Million-56.85%
2016 -C$17.29 Million-79.31%
2015 -C$83.54 Million63.85%
2014 -C$50.99 Million31.04%
2013 -C$38.91 Million-21.96%
2012 -C$49.86 Million
2010 -C$47.55 Million-42.38%
2009 -C$82.53 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$74.86 Million209.75%
2006 -C$24.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.11 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.31 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$9.52 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$43.26 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.14 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.13 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.69 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA